Forty Seven Inc (FTSV)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: FTSV Exchange: NSM


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2020-04-03 2020-04-01 S Sale

McCamish Mark Anthony

President and CEO

Executive Director
30,237 -86.8%
95.42
2,885,236 USD 		30,237 -86.8% 95.42 2,885,236 USD
2020-04-03 2020-04-01 S Sale

McCamish Mark Anthony

President and CEO

Executive Director
2,340 -6.3%
95.41
223,268 USD 		2,340 -6.3% 95.41 223,268 USD
2020-04-03 2020-04-01 S Sale

RHOADS ANN D

Chief Financial Officer

Officer
1,924 -4.9%
95.43
183,598 USD 		1,924 -4.9% 95.43 183,598 USD
2020-04-03 2020-04-01 S Sale

Takimoto Chris H

Chief Medical Officer

Officer
79,195 -95.3%
95.42
7,556,787 USD 		79,195 -95.3% 95.42 7,556,787 USD
2020-03-16 2020-03-12 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
200 -0.0%
93.74
18,748 USD 		200 -0.0% 93.74 18,748 USD
2020-03-16 2020-03-12 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
42,095 -2.3%
93.29
3,926,878 USD 		42,095 -2.3% 93.29 3,926,878 USD
2020-03-16 2020-03-12 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
10,800 -0.6%
92.19
995,635 USD 		10,800 -0.6% 92.19 995,635 USD
2020-03-16 2020-03-11 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
196,905 -9.8%
94.72
18,650,212 USD 		196,905 -9.8% 94.72 18,650,212 USD
2020-02-19 2020-02-18 PS Planned sale

Majeti Ravindra

Non-Executive Director
375 -0.0%
45.87
17,202 USD 		375 -0.0% 45.87 17,202 USD
2020-02-19 2020-02-18 PS Planned sale

Majeti Ravindra

Non-Executive Director
11,420 -1.1%
45.17
515,795 USD 		11,420 -1.1% 45.17 515,795 USD
2020-02-19 2020-02-18 PS Planned sale

Majeti Ravindra

Non-Executive Director
7,493 -0.7%
44.05
330,052 USD 		7,493 -0.7% 44.05 330,052 USD
2020-02-19 2020-02-18 PS Planned sale

Majeti Ravindra

Non-Executive Director
5,712 -0.5%
43.15
246,466 USD 		5,712 -0.5% 43.15 246,466 USD
2020-01-16 2020-01-15 PS Planned sale

Majeti Ravindra

1,011 -0.1%
36.78
37,187 USD 		1,011 -0.1% 36.78 37,187 USD
2020-01-16 2020-01-15 PS Planned sale

Majeti Ravindra

23,989 -2.2%
36.33
871,511 USD 		23,989 -2.2% 36.33 871,511 USD
2019-12-30 2019-12-26 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
6,115 -0.3%
44.78
273,830 USD 		6,115 -0.3% 44.78 273,830 USD
2019-12-30 2019-12-26 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
23,885 -1.2%
44.08
1,052,851 USD 		23,885 -1.2% 44.08 1,052,851 USD
2019-12-17 2019-12-16 PS Planned sale

Majeti Ravindra

Non-Executive Director
7,004 -0.6%
35.87
251,226 USD 		7,004 -0.6% 35.87 251,226 USD
2019-12-17 2019-12-16 PS Planned sale

Majeti Ravindra

Non-Executive Director
17,996 -1.6%
35.34
635,943 USD 		17,996 -1.6% 35.34 635,943 USD
2019-12-11 2019-12-10 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
35.00
350,000 USD 		10,000 -100.0% 35.00 350,000 USD
2019-12-10 2019-12-09 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
10,180 -0.5%
17.25
175,646 USD 		10,180 -0.5% 17.25 175,646 USD
2019-12-10 2019-12-09 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
9,820 -0.5%
15.15
148,763 USD 		9,820 -0.5% 15.15 148,763 USD
2019-12-10 2019-12-09 PS Planned sale

Majeti Ravindra

Non-Executive Director
20,000 -1.7%
22.00
440,000 USD 		20,000 -1.7% 22.00 440,000 USD
2019-12-10 2019-12-09 PS Planned sale

Majeti Ravindra

Non-Executive Director
20,000 -1.7%
20.00
400,000 USD 		20,000 -1.7% 20.00 400,000 USD
2019-12-10 2019-12-09 PS Planned sale

Majeti Ravindra

Non-Executive Director
20,000 -1.7%
18.00
360,000 USD 		20,000 -1.7% 18.00 360,000 USD
2019-12-10 2019-12-09 PS Planned sale

Majeti Ravindra

Non-Executive Director
5,000 -0.4%
15.00
75,000 USD 		5,000 -0.4% 15.00 75,000 USD
2019-12-10 2019-12-09 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
10,000 -100.0%
30.00
300,000 USD 		10,000 -100.0% 30.00 300,000 USD
2019-11-22 2019-11-20 PS Planned sale

Majeti Ravindra

Non-Executive Director
5,000 -0.4%
12.50
62,500 USD 		5,000 -0.4% 12.50 62,500 USD
2019-11-20 2019-11-18 PS Planned sale

Majeti Ravindra

15,000 -1.2%
10.26
153,915 USD 		15,000 -1.2% 10.26 153,915 USD
2019-08-21 2019-08-16 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
663 -100.0%
6.36
4,216 USD 		663 -100.0% 6.36 4,216 USD
2019-07-24 2019-07-22 B Purchase

BIRD JEFFREY W

187,500 +3811.8%
8.00
1,500,000 USD 		187,500 +3811.8% 8.00 1,500,000 USD
2019-07-24 2019-07-22 B Purchase

BIRD JEFFREY W

562,500 +inf%
8.00
4,500,000 USD 		562,500 +inf% 8.00 4,500,000 USD
2019-07-24 2019-07-22 B Purchase

Lightspeed Venture Partners X, L.P.

Large shareholder
312,500 +17.5%
8.00
2,500,000 USD 		312,500 +17.5% 8.00 2,500,000 USD
2019-07-24 2019-07-22 B Purchase

Lightspeed Venture Partners X, L.P.

Large shareholder
312,500 +12.6%
8.00
2,500,000 USD 		312,500 +12.6% 8.00 2,500,000 USD
2019-06-27 2019-06-25 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
8,199 -11.9%
11.02
90,391 USD 		8,199 -11.9% 11.02 90,391 USD
2019-06-24 2019-06-20 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
8,301 -12.0%
11.04
91,626 USD 		8,301 -12.0% 11.04 91,626 USD
2019-05-22 2019-05-20 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
1,291 -2.1%
12.46
16,080 USD 		1,291 -2.1% 12.46 16,080 USD
2019-05-22 2019-05-20 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
15,209 -20.0%
12.07
183,646 USD 		15,209 -20.0% 12.07 183,646 USD
2019-05-17 2019-05-16 PS Planned sale

Majeti Ravindra

2,088 -0.1%
16.02
33,460 USD 		2,088 -0.1% 16.02 33,460 USD
2019-05-17 2019-05-15 PS Planned sale

Majeti Ravindra

2,223 -0.2%
16.01
35,584 USD 		2,223 -0.2% 16.01 35,584 USD
2019-05-07 2019-05-03 PS Planned sale

Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
17.99
143,951 USD 		8,000 -100.0% 17.99 143,951 USD
2019-04-30 2019-04-26 PS Planned sale

WEISSMAN IRVING

20,000 -1.0%
18.35
366,978 USD 		20,000 -1.0% 18.35 366,978 USD
2019-04-22 2019-04-18 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.12
299,054 USD 		16,500 -21.4% 18.12 299,054 USD
2019-04-17 2019-04-15 PS Planned sale

Majeti Ravindra

25,000 -1.7%
18.30
457,505 USD 		25,000 -1.7% 18.30 457,505 USD
2019-04-05 2019-04-05 PS Planned sale

WEISSMAN IRVING

6,518 -0.3%
17.15
111,799 USD 		6,518 -0.3% 17.15 111,799 USD
2019-04-08 2019-04-04 PS Planned sale

Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.39
131,105 USD 		8,000 -100.0% 16.39 131,105 USD
2019-04-05 2019-04-03 PS Planned sale

WEISSMAN IRVING

3,382 -0.2%
17.04
57,632 USD 		3,382 -0.2% 17.04 57,632 USD
2019-04-02 2019-03-29 PS Planned sale

WEISSMAN IRVING

100 -0.0%
18.00
1,800 USD 		100 -0.0% 18.00 1,800 USD
2019-03-28 2019-03-26 PS Planned sale

WEISSMAN IRVING

10,000 -0.5%
15.98
159,812 USD 		10,000 -0.5% 15.98 159,812 USD
2019-03-21 2019-03-19 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
16,500 -21.4%
18.15
299,401 USD 		16,500 -21.4% 18.15 299,401 USD
2019-03-19 2019-03-19 PS Planned sale

Majeti Ravindra

5,292 -0.4%
18.03
95,398 USD 		5,292 -0.4% 18.03 95,398 USD
2019-03-19 2019-03-18 PS Planned sale

Majeti Ravindra

9,708 -0.7%
18.02
174,938 USD 		9,708 -0.7% 18.02 174,938 USD
2019-03-19 2019-03-15 PS Planned sale

Majeti Ravindra

20,000 -1.3%
17.68
353,616 USD 		20,000 -1.3% 17.68 353,616 USD
2019-03-06 2019-03-04 PS Planned sale

Takimoto Chris H

Chief Medical Officer
8,000 -100.0%
16.94
135,550 USD 		8,000 -100.0% 16.94 135,550 USD
2019-03-05 2019-03-01 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
3,616 -0.2%
17.04
61,603 USD 		3,616 -0.2% 17.04 61,603 USD
2019-02-27 2019-02-27 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
4,280 -0.2%
17.01
72,805 USD 		4,280 -0.2% 17.01 72,805 USD
2019-02-27 2019-02-26 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
12,104 -0.6%
16.93
204,973 USD 		12,104 -0.6% 16.93 204,973 USD
2019-02-27 2019-02-25 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
10,000 -0.5%
17.03
170,325 USD 		10,000 -0.5% 17.03 170,325 USD
2019-02-26 2019-02-25 PS Planned sale

Majeti Ravindra

Non-Executive Director
10,266 -0.7%
16.07
164,990 USD 		10,266 -0.7% 16.07 164,990 USD
2019-02-26 2019-02-22 PS Planned sale

Majeti Ravindra

Non-Executive Director
22,371 -1.5%
16.01
358,131 USD 		22,371 -1.5% 16.01 358,131 USD
2019-02-21 2019-02-20 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
9,410 -13.4%
14.94
140,546 USD 		9,410 -13.4% 14.94 140,546 USD
2019-02-21 2019-02-19 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
2,500 -100.0%
15.05
37,621 USD 		2,500 -100.0% 15.05 37,621 USD
2019-02-21 2019-02-19 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
7,090 -10.5%
15.06
106,797 USD 		7,090 -10.5% 15.06 106,797 USD
2019-02-05 2019-02-04 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
14.86
118,874 USD 		8,000 -100.0% 14.86 118,874 USD
2019-02-05 2019-02-04 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
6,445 -0.3%
15.02
96,805 USD 		6,445 -0.3% 15.02 96,805 USD
2019-02-05 2019-02-01 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
3,219 -0.2%
15.02
48,362 USD 		3,219 -0.2% 15.02 48,362 USD
2019-02-01 2019-01-31 PS Planned sale

Majeti Ravindra

Non-Executive Director
3,834 -0.3%
14.57
55,872 USD 		3,834 -0.3% 14.57 55,872 USD
2019-02-01 2019-01-30 PS Planned sale

Majeti Ravindra

Non-Executive Director
16,166 -1.1%
14.46
233,683 USD 		16,166 -1.1% 14.46 233,683 USD
2019-01-30 2019-01-28 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
336 -0.0%
15.00
5,041 USD 		336 -0.0% 15.00 5,041 USD
2019-01-23 2019-01-18 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
20,000 -68.9%
14.59
291,892 USD 		20,000 -68.9% 14.59 291,892 USD
2019-01-17 2019-01-16 PS Planned sale

Majeti Ravindra

Non-Executive Director
4,363 -0.3%
16.00
69,822 USD 		4,363 -0.3% 16.00 69,822 USD
2019-01-17 2019-01-15 PS Planned sale

Majeti Ravindra

Non-Executive Director
23,000 -1.5%
15.73
361,808 USD 		23,000 -1.5% 15.73 361,808 USD
2019-01-11 2019-01-09 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
10,000 -0.5%
17.05
170,490 USD 		10,000 -0.5% 17.05 170,490 USD
2019-01-08 2019-01-04 PS Planned sale

Takimoto Chris H

Chief Medical Officer

Officer
8,000 -100.0%
15.55
124,362 USD 		8,000 -100.0% 15.55 124,362 USD
2019-01-11 2018-12-26 PS Planned sale

WEISSMAN IRVING

Non-Executive Director
10,000 -0.5%
15.77
157,685 USD 		10,000 -0.5% 15.77 157,685 USD
2018-12-28 2018-12-26 PS Planned sale

McCamish Mark Anthony

President and CEO

Executive Director
2,968 -24.7%
15.89
47,160 USD 		2,968 -24.7% 15.89 47,160 USD